Maxim raised the firm’s price target on Rezolute (RZLT) to $20 from $15 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RZLT:
- Rezolute’s Promising Progress and Financial Strength Justify Buy Rating
- Rezolute’s Promising Outlook: Buy Rating Affirmed Amid Strategic Advancements and Strong Clinical Progress
- Rezolute, Inc. Reports Fiscal 2025 Financial Results
- Rezolute reports Q4 EPS (26c), consensus (23c)
- Rezolute, Inc. (RZLT) Q4 Earnings Cheat Sheet